High Fever Occurring 4 to 5 Days Post-Transplant of Haploidentical Bone Marrow or Peripheral Blood Stem Cells after Reduced-Intensity Conditioning Associated with the Use of Post-Transplant Cyclophosphamide as Prophylaxis for Graft-versus-Host Disease-Reference-Cited by-同舟云学术

High Fever Occurring 4 to 5 Days Post-Transplant of Haploidentical Bone Marrow or Peripheral Blood Stem Cells after Reduced-Intensity Conditioning Associated with the Use of Post-Transplant Cyclophosphamide as Prophylaxis for Graft-versus-Host Disease

Published:2015-01 Issue:1 Volume:21 Page:197-198
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

O’Donnell Paul,Raj Kavita,Pagliuca Antonio

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference8 articles.

1. Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide;Castagna;Biol Blood Marrow Transplant,2014

2. Peripheral blood stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced intensity conditioning;Raj;Biol Blood Marrow Transplant,2014

3. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, post transplantation cylophosphamide;Luznik;Biol Blood Marrow Transplant,2008

4. Peripheral blood progenitor cell (PBPC) transplantation from haploidentical donors following reduced intensity conditioning (RIC) for high-risk hematolgic malignancies;Raj;Biol Blood Marrow Transplant,2012

5. Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide;Leukemia & Lymphoma;2024-05-06

2. Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis;Transplantation and Cellular Therapy;2023-08

3. Diagnosis and Management of Adult Malignancy-Associated Hemophagocytic Lymphohistiocytosis;Cancers;2023-03-18

4. Cytokine Release Syndrome and Associated Acute Toxicities in Pediatric Patients Undergoing Immune Effector Cell Therapy or Hematopoietic Cell Transplantation;Frontiers in Oncology;2022-03-24

5. Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease;Transplant Infectious Disease;2022-03-10